These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3643709)

  • 21. Drug targeting to the liver with lactosylated albumins: does the glycoprotein target the drug or is the drug targeting the glycoprotein?
    van der Sluijs P; Bootsma HP; Postema B; Moolenaar F; Meijer DK
    Hepatology; 1986; 6(4):723-8. PubMed ID: 3089897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating autoantibodies to mammalian tissue kallikreins.
    Chao J; Mayfield RK; Chao L
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):320-6. PubMed ID: 3347609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between clearance rates of plasma kallikrein and of plasma kallikrein-alpha-macroglobulin complexes by the liver.
    Ogata H; Kouyoumdjian M; Borges DR
    Int J Biochem; 1993 Jul; 25(7):1047-51. PubMed ID: 7689988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of renal kallikrein to the perfusate by isolated rat kidney.
    Roblero JS; Croxatto HR; Albertini RB
    Experientia; 1976 Nov; 32(11):1440-1. PubMed ID: 991989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kallikrein secretion by the isolated perfused rat kidney. Role of perfusion pressure and the renin-angiotensin system].
    Gardes J; Misumi J; Gonzalez MF; Alhenc-Gélas F; Corvol P; Ménard J
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1677-80. PubMed ID: 3938240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor.
    Dragsten PR; Mitchell DB; Covert G; Baker T
    Biochim Biophys Acta; 1987 Dec; 926(3):270-9. PubMed ID: 3689826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Braz J Med Biol Res; 2000 Jan; 33(1):119-25. PubMed ID: 10625883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma kallikrein clearance by the liver of normal and injured rats.
    Toledo CF; Kouyoumdjian M; Borges DR
    Adv Exp Med Biol; 1989; 247B():591-4. PubMed ID: 2610095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake and intracellular processing of galactosyl-neoglycoalbumin by the isolated perfused rat liver.
    Gore S; Morris AI; Gilmore IT; Billington D
    Biochem Soc Trans; 1990 Apr; 18(2):291-2. PubMed ID: 2379723
    [No Abstract]   [Full Text] [Related]  

  • 30. The kallikrein--kinin system in blood vessels.
    Nolly HL; Lama MC; Carretero OA; Scicli AG
    Agents Actions Suppl; 1992; 38 ( Pt 3)():1-9. PubMed ID: 1462850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants.
    Windler E; Greeve J; Levkau B; Kolb-Bachofen V; Daerr W; Greten H
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):79-87. PubMed ID: 1645533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on kallikreins. III. Intra-intestinal administration of hog pancreatic kallikrein and its appearance in the perfusate from the mesenteric vein.
    Moriwaki C; Yamaguchi K; Moriya H
    Chem Pharm Bull (Tokyo); 1974 Sep; 22(9):1975-80. PubMed ID: 4217660
    [No Abstract]   [Full Text] [Related]  

  • 34. The clearance rate of plasma kallikrein by the liver increases during the acute-phase response to inflammation.
    Martins B; Kouyoumdjian M; Limaos EA; Borges DR
    Agents Actions; 1992 Sep; 37(1-2):111-3. PubMed ID: 1456171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kallikrein release by vascular tissue.
    Nolly H; Carretero OA; Scicli AG
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1209-14. PubMed ID: 8238407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved method for the measurement of rat tissue kallikrein using a monoclonal antibody which recognizes only active enzyme.
    Ando T; Chao J; Chao L; Margolius HS
    Adv Exp Med Biol; 1986; 198 Pt B():515-22. PubMed ID: 3643738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte.
    Schiff JM; Fisher MM; Jones AL; Underdown BJ
    J Cell Biol; 1986 Mar; 102(3):920-31. PubMed ID: 3949883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and partial characterization of cat pancreatic and urinary kallikreins--comparison with other cat tissue kallikreins and related proteases.
    Fujimori H; Levison PR; Schachter M
    Adv Exp Med Biol; 1986; 198 Pt A():219-28. PubMed ID: 3544713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose-independent manner.
    Bennatt DJ; Ling YY; McAbee DD
    Biochemistry; 1997 Jul; 36(27):8367-76. PubMed ID: 9204884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of inactive plasma renin by tissue kallikreins.
    Derkx FH; Tan-Tjiong HL; Man in't Veld AJ; Schalekamp MP; Schalekamp MA
    J Clin Endocrinol Metab; 1979 Nov; 49(5):765-9. PubMed ID: 489716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.